198 related articles for article (PubMed ID: 19925406)
1. The angiogenic switch: implications in the regulation of tumor dormancy.
Moserle L; Amadori A; Indraccolo S
Curr Mol Med; 2009 Nov; 9(8):935-41. PubMed ID: 19925406
[TBL] [Abstract][Full Text] [Related]
2. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch.
Naumov GN; Akslen LA; Folkman J
Cell Cycle; 2006 Aug; 5(16):1779-87. PubMed ID: 16931911
[TBL] [Abstract][Full Text] [Related]
3. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
Favaro E; Amadori A; Indraccolo S
APMIS; 2008; 116(7-8):648-59. PubMed ID: 18834409
[TBL] [Abstract][Full Text] [Related]
4. Dormant tumors awaken by a short-term angiogenic burst: the spike hypothesis.
Indraccolo S; Favaro E; Amadori A
Cell Cycle; 2006 Aug; 5(16):1751-5. PubMed ID: 16861908
[TBL] [Abstract][Full Text] [Related]
5. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.
Almog N; Ma L; Schwager C; Brinkmann BG; Beheshti A; Vajkoczy P; Folkman J; Hlatky L; Abdollahi A
PLoS One; 2012; 7(8):e44001. PubMed ID: 22952847
[TBL] [Abstract][Full Text] [Related]
6. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic switch in carcinogenesis.
Baeriswyl V; Christofori G
Semin Cancer Biol; 2009 Oct; 19(5):329-37. PubMed ID: 19482086
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of angiogenesis in cancers.
Pang RW; Poon RT
Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor as an angiogenic factor.
Nico B; Mangieri D; Benagiano V; Crivellato E; Ribatti D
Microvasc Res; 2008 Mar; 75(2):135-41. PubMed ID: 17764704
[TBL] [Abstract][Full Text] [Related]
12. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
[TBL] [Abstract][Full Text] [Related]
13. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.
Naumov GN; Bender E; Zurakowski D; Kang SY; Sampson D; Flynn E; Watnick RS; Straume O; Akslen LA; Folkman J; Almog N
J Natl Cancer Inst; 2006 Mar; 98(5):316-25. PubMed ID: 16507828
[TBL] [Abstract][Full Text] [Related]
14. Tumor dormancy and the angiogenic switch: possible implications of bone marrow- derived cells.
Shaked Y; McAllister S; Fainaru O; Almog N
Curr Pharm Des; 2014; 20(30):4920-33. PubMed ID: 24283950
[TBL] [Abstract][Full Text] [Related]
15. Integration of pro- and anti-angiogenic signals by endothelial cells.
Kazerounian S; Lawler J
J Cell Commun Signal; 2018 Mar; 12(1):171-179. PubMed ID: 29264709
[TBL] [Abstract][Full Text] [Related]
16. The history of the angiogenic switch concept.
Ribatti D; Nico B; Crivellato E; Roccaro AM; Vacca A
Leukemia; 2007 Jan; 21(1):44-52. PubMed ID: 16990761
[TBL] [Abstract][Full Text] [Related]
17. Exosomes in Tumor Angiogenesis.
Salem KZ; Moschetta M; Sacco A; Imberti L; Rossi G; Ghobrial IM; Manier S; Roccaro AM
Methods Mol Biol; 2016; 1464():25-34. PubMed ID: 27858353
[TBL] [Abstract][Full Text] [Related]
18. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data.
Natale G; Bocci G
Cancer Lett; 2018 Sep; 432():28-37. PubMed ID: 29885517
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
20. The host support niche as a control point for tumor dormancy: implications for tumor development and beyond.
Hahnfeldt P
Adv Exp Med Biol; 2013; 734():19-35. PubMed ID: 23143973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
